Tag: immunoassay

Driven by intensifying food safety requirements with the increased stringency of regulatory guidelines, a substantial and growing incidence of food fraud across global supply...

Driven by intensifying food safety requirements with the increased stringency of regulatory guidelines, a substantial and growing incidence of food fraud across global supply...

The Biomarkers Market is anticipated to expand at a rapid pace due to the increasing demand for personalized medicine, rising prevalence of chronic and...

SALEM, N.H., July 28, 2025 /PRNewswire/ -- NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its...

Basel, 28 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer’s development portfolio is being presented at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data exemplify the comprehensive approach Roche is taking in addressing Alzheimer’s across the entire patient journey. 

WOBURN, Mass., July 25, 2025 /PRNewswire/ -- Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, today announced the commercial launch of its...

SAN DIEGO, July 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed...

STOCKHOLM, July 22, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®), including...

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

The diagnostic industry sees a surge in demand for rapid solutions, with immunoassays leading the charge. Fueled by genetic advances, multiplex assays become essential, expanding into rapid diagnostics and consumer markets. Analyze profiles of 60+ companies for informed investment decisions.

The diagnostic industry sees a surge in demand for rapid solutions, with immunoassays leading the charge. Fueled by genetic advances, multiplex assays become essential, expanding into rapid diagnostics and consumer markets. Analyze profiles of 60+ companies for informed investment decisions.